Earnings Feed
Start Free
Home/Filings/4/0001181431-10-044485
4//SEC Filing

ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. 4

Accession 0001181431-10-044485

$MDRXCIK 0001124804operating
View on SEC.govCompany Profile

Filed

Aug 25, 8:00 PM ET

Accepted

Aug 26, 6:58 PM ET

Size

22.6 KB

Accession

0001181431-10-044485

Insider Transaction Report

Form 4
Period: 2010-08-24
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.MDRX
GOMEZ JOHN
Pre, Product Strategy & Dev
Transactions
  • Award

    Option to buy

    2010-08-24+144,000→ 144,000 total
    Exercise: $11.13From: 2010-08-24Exp: 2014-02-04→ Common Stock (144,000 underlying)
  • Award

    Option to buy

    2010-08-24+42,000→ 42,000 total
    Exercise: $18.39Exp: 2015-03-04→ Common Stock (42,000 underlying)
  • Award

    Option to buy

    2010-08-24+168,000→ 168,000 total
    Exercise: $16.42From: 2010-08-24Exp: 2014-12-01→ Common Stock (168,000 underlying)
  • Award

    Option to buy

    2010-08-24+60,000→ 60,000 total
    Exercise: $9.96From: 2010-08-24Exp: 2013-10-22→ Common Stock (60,000 underlying)
  • Award

    Option to buy

    2010-08-24+126,000→ 126,000 total
    Exercise: $6.64Exp: 2016-02-27→ Common Stock (126,000 underlying)
  • Award

    Common Stock

    2010-08-24+76,500→ 76,500 total
  • Award

    Option to buy

    2010-08-24+36,000→ 36,000 total
    Exercise: $11.05From: 2010-08-24Exp: 2013-08-11→ Common Stock (36,000 underlying)
  • Award

    Performance Stock Units

    2010-08-24+60,000→ 60,000 total
    Exercise: $0.00Exp: 2013-03-15→ Common stock (60,000 underlying)
Footnotes (12)
  • [F1]Received pursuant to the Agreement and Plan of Merger, dated as of June 9, 2010, among Allscripts-Misys Healthcare Solutions, Inc. (which has changed its name to Allscripts Healthcare Solutions, Inc.) ("Allscripts"), Arsenal Merger Corp. and Eclipsys Corporation (the "Merger Agreement") in exchange for 63,750 shares held directly. On the effective date of the merger, the closing price of Allscripts Healthcare Solutions, Inc. common stock was $17.47 per share.
  • [F10]Each Performance Stock Unit ("PSU") represents a contingent right to receive a number of shares of Allscripts common stock ranging from zero to 2.7, depending upon Eclipsys' total shareholder return ("TSR") compared to the TSRs of a group of pre-selected companies in the healthcare technology and software industries over a performance period commencing on March 15, 2010 ending on August 24, 2010, the effective date of the merger.
  • [F11]Assumes Eclipsys' TSR was at the 50th percentile of the comparison group. Actual payout for PSUs can range from 0% to 270% of the amount shown depending upon relative TSRs for the performance period.
  • [F12]Received pursuant to the Merger Agreement in exchange for an identical number of performance share units payable in Eclipsys Corporation common stock.
  • [F2]Received pursuant to the Merger Agreement in exchange for a stock option to acquire 30,000 shares of Eclipsys Corporation common stock for $13.26 per share.
  • [F3]Received pursuant to the Merger Agreement in exchange for a stock option to acquire 50,000 shares of Eclipsys Corporation common stock for $11.95 per share.
  • [F4]Received pursuant to the Merger Agreement in exchange for a stock option to acquire 120,000 shares of Eclipsys Corporation common stock for $13.35 per share.
  • [F5]Received pursuant to the Merger Agreement in exchange for a stock option to acquire 140,000 shares of Eclipsys Corporation common stock for $19.70 per share.
  • [F6]The option may be exercised only to the extent vested. The option is vested with respect to 60.4167% of the underlying shares, and vests with respect to the remaining 39.5833% in 19 equal monthly installments over the nineteen-month period ending March 4, 2012.
  • [F7]Received pursuant to the Merger Agreement in exchange for a stock option to acquire 35,000 shares of Eclipsys Corporation common stock for $22.07 per share.
  • [F8]The option may be exercised only to the extent vested. The option is vested with respect to 35.4167% of the underlying shares, and vests with respect to the remaining 64.5833% in 31 equal monthly installments over the thirty-one-month period ending February 27, 2013.
  • [F9]Received pursuant to the Merger Agreement in exchange for a stock option to acquire 105,000 shares of Eclipsys Corporation common stock for $7.97 per share.

Documents

1 file

Issuer

ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.

CIK 0001124804

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001124804

Filing Metadata

Form type
4
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 6:58 PM ET
Size
22.6 KB
View on SEC.gov